Home NDC 0093-0109 Carbamazepine
Product NDC 0093-0109
11-digit product format 000930109
Labeler code 0093
Product ID 0093-0109_042aa2c6-95ff-410a-abcf-a8ee79fa96d8
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Carbamazepine
Dosage form TABLET
Route ORAL
Labeler Teva Pharmaceuticals USA, Inc.
Application ANDA070541
Marketing category ANDA
Marketing start 1990-09-30
Marketing end 2026-07-31
Substance CARBAMAZEPINE
Active strength 200 mg/1
Pharmacologic classes Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
NDC exclude flag No
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A070541-001 EPITOL CARBAMAZEPINE 200MG TABLET / ORAL AB 1986-09-17
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A070541-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A070541-001 EPITOL 200MG TABLET / ORAL AB 1986-09-17 e64feba35796…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 42 observed states.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0093-0109-01 Carbamazepine 100 in 1 BOTTLE TABLET 100 28 0093-0109-10 Carbamazepine 1000 in 1 BOTTLE TABLET 1000 28
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CARBAMAZEPINE ACTIVE INGREDIENT 33CM23913M CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC] 16 CARBAMAZEPINE ACTIVE MOIETY 33CM23913M CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC] 16 ACACIA INACTIVE INGREDIENT 5C5403N26O CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC] 16 ALUMINUM OXIDE INACTIVE INGREDIENT LMI26O6933 CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC] 16 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC] 16 ETHYLCELLULOSE (100 MPA.S) INACTIVE INGREDIENT 47MLB0F1MV CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC] 16 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC] 16 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC] 16 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC] 16 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC] 16 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC] 16 SODIUM STARCH GLYCOLATE TYPE A POTATO INACTIVE INGREDIENT 5856J3G2A2 CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC] 16 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC] 16 SUCROSE INACTIVE INGREDIENT C151H8M554 CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC] 16 CARBAMAZEPINE ACTIVE INGREDIENT 33CM23913M CARBAMAZEPINE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 CARBAMAZEPINE ACTIVE MOIETY 33CM23913M CARBAMAZEPINE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 CARBAMAZEPINE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 ETHYLCELLULOSES INACTIVE INGREDIENT 7Z8S9VYZ4B CARBAMAZEPINE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX CARBAMAZEPINE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X CARBAMAZEPINE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 CARBAMAZEPINE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 CARBAMAZEPINE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 SODIUM STARCH GLYCOLATE TYPE A POTATO INACTIVE INGREDIENT 5856J3G2A2 CARBAMAZEPINE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] 8 CARBAMAZEPINE ACTIVE INGREDIENT 33CM23913M CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.] 7 CARBAMAZEPINE ACTIVE MOIETY 33CM23913M CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.] 7 ACACIA INACTIVE INGREDIENT 5C5403N26O CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.] 7 ALUMINUM OXIDE INACTIVE INGREDIENT LMI26O6933 CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.] 7 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.] 7 ETHYLCELLULOSE (100 MPA.S) INACTIVE INGREDIENT 47MLB0F1MV CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.] 7 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.] 7 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.] 7 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.] 7 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.] 7 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.] 7 SODIUM STARCH GLYCOLATE TYPE A POTATO INACTIVE INGREDIENT 5856J3G2A2 CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.] 7 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.] 7 SUCROSE INACTIVE INGREDIENT C151H8M554 CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.] 7 CARBAMAZEPINE ACTIVE INGREDIENT 33CM23913M CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [PHYSICIANS TOTAL CARE, INC.] 2 CARBAMAZEPINE ACTIVE INGREDIENT 33CM23913M CARBAMAZEPINE TABLET [REBEL DISTRIBUTORS CORP] 2 CARBAMAZEPINE ACTIVE MOIETY 33CM23913M CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [PHYSICIANS TOTAL CARE, INC.] 2 CARBAMAZEPINE ACTIVE MOIETY 33CM23913M CARBAMAZEPINE TABLET [REBEL DISTRIBUTORS CORP] 2 ACACIA INACTIVE INGREDIENT 5C5403N26O CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [PHYSICIANS TOTAL CARE, INC.] 2 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U CARBAMAZEPINE TABLET [REBEL DISTRIBUTORS CORP] 2 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [PHYSICIANS TOTAL CARE, INC.] 2 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 CARBAMAZEPINE TABLET [REBEL DISTRIBUTORS CORP] 2 DIETHYL PHTHALATE INACTIVE INGREDIENT UF064M00AF CARBAMAZEPINE TABLET [REBEL DISTRIBUTORS CORP] 2 ETHYLCELLULOSES INACTIVE INGREDIENT 7Z8S9VYZ4B CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [PHYSICIANS TOTAL CARE, INC.] 2 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [PHYSICIANS TOTAL CARE, INC.] 2 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [PHYSICIANS TOTAL CARE, INC.] 2 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [PHYSICIANS TOTAL CARE, INC.] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [PHYSICIANS TOTAL CARE, INC.] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 CARBAMAZEPINE TABLET [REBEL DISTRIBUTORS CORP] 2 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [PHYSICIANS TOTAL CARE, INC.] 2 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [PHYSICIANS TOTAL CARE, INC.] 2 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ CARBAMAZEPINE TABLET [REBEL DISTRIBUTORS CORP] 2 SUCROSE INACTIVE INGREDIENT C151H8M554 CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [PHYSICIANS TOTAL CARE, INC.] 2 CARBAMAZEPINE ACTIVE INGREDIENT 33CM23913M CARBAMAZEPINE TABLET [CONTRACT PHARMACY SERVICES-PA] 1 CARBAMAZEPINE ACTIVE INGREDIENT 33CM23913M CARBAMAZEPINE TABLET [STAT RX USA LLC] 1 CARBAMAZEPINE ACTIVE MOIETY 33CM23913M CARBAMAZEPINE TABLET [CONTRACT PHARMACY SERVICES-PA] 1 CARBAMAZEPINE ACTIVE MOIETY 33CM23913M CARBAMAZEPINE TABLET [STAT RX USA LLC] 1 COLLOIDAL SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 CARBAMAZEPINE TABLET [CONTRACT PHARMACY SERVICES-PA] 1 COLLOIDAL SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 CARBAMAZEPINE TABLET [STAT RX USA LLC] 1 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 CARBAMAZEPINE TABLET [CONTRACT PHARMACY SERVICES-PA] 1 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 CARBAMAZEPINE TABLET [STAT RX USA LLC] 1 ETHYLCELLULOSE INACTIVE INGREDIENT 7Z8S9VYZ4B CARBAMAZEPINE TABLET [CONTRACT PHARMACY SERVICES-PA] 1 ETHYLCELLULOSE INACTIVE INGREDIENT 7Z8S9VYZ4B CARBAMAZEPINE TABLET [STAT RX USA LLC] 1 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX CARBAMAZEPINE TABLET [CONTRACT PHARMACY SERVICES-PA] 1 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX CARBAMAZEPINE TABLET [STAT RX USA LLC] 1 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X CARBAMAZEPINE TABLET [CONTRACT PHARMACY SERVICES-PA] 1 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X CARBAMAZEPINE TABLET [STAT RX USA LLC] 1 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 CARBAMAZEPINE TABLET [CONTRACT PHARMACY SERVICES-PA] 1 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 CARBAMAZEPINE TABLET [STAT RX USA LLC] 1
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0093-0109-01 00093010901 100 TABLET in 1 BOTTLE (0093-0109-01) 100 tablet 1990-09-30 2026-06-30 No No Current 0093-0109-10 00093010910 1000 TABLET in 1 BOTTLE (0093-0109-10) 1000 tablet 1990-09-30 2026-07-31 No No Current